MiR-429 Inhibits Oral Squamous Cell Carcinoma Growth by Targeting ZEB1

BACKGROUND: Oral squamous cell carcinoma (OSCC) is the sixth most common human malignancy worldwide. To develop new therapeutics requires elucidation of the underlying mechanism of OSCC pathogenesis. The role of miR-429 in OSCC remains unknown. MATERIAL/METHODS: The level of miR-429 and ZEB1 in OSCC...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Wanke, Liu, Yun-e, Zheng, Yuzhu, Qu, AG Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2015
Materias:
Molecular Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324578/
https://www.ncbi.nlm.nih.gov/pubmed/25640197
http://dx.doi.org/10.12659/MSM.893412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324578/
https://www.ncbi.nlm.nih.gov/pubmed/25640197
http://dx.doi.org/10.12659/MSM.893412

Ejemplares similares